Abstract
Identifier: NCT05419024. This protocol outlines a clinical study designed to map the HIV reservoir using FDG-PET/CT imaging to identify metabolic "hot spots" in lymphoid tissue during Analytic Treatment Interruption (ATI).
Introduction: The Challenge of the HIV Reservoir
Antiretroviral Therapy (ART) has transformed HIV into a manageable chronic condition by suppressing viral loads to undetectable levels in the blood. However, ART is not a cure. The virus persists in latent "reservoirs," primarily within lymphoid tissues such as lymph nodes and the spleen. Upon cessation of ART, the virus typically rebounds from these sites.
A significant gap in current HIV research is the lack of spatial understanding regarding this rebound. While we know the virus returns, identifying the specific "factories" or anatomical locations where replication resumes in a living patient remains difficult. Traditional peripheral blood mononuclear cell (PBMC) analysis lacks spatial context. To advance "shock and kill" or "block and lock" strategies, researchers require non-invasive methods to visualize and target these active reservoirs.
Study Design and Methods
The proposed study (NCT05419024) is a single-site randomized trial involving 12 HIV-infected adults who have maintained viral suppression on ART for at least three years.
Randomization and Intervention
Participants are randomized 1:1 into two groups:
- Analytic Treatment Interruption (ATI) Arm (n=6): Participants temporarily pause ART under rigorous clinical supervision.
- Control Arm (n=6): Participants continue their standard ART regimen.
Imaging and Precision Biopsy
The study utilizes $^{18}$F-fluorodeoxyglucose (FDG) PET/CT imaging. FDG, a glucose analog, identifies areas of high metabolic activity, which may correlate with active viral replication or localized immune activation.
Following imaging, interventional radiologists perform precision biopsies on both "hot" (high FDG uptake) and "cold" (low uptake) lymph nodes. This is achieved using advanced guidance systems, including electromagnetic tracking and ultrasound, to ensure accurate tissue sampling. Biopsies occur at three critical time points: baseline, approximately 10 days post-ART interruption (during the rebound phase), and after ART resumption once viral suppression is re-established.
Comprehensive Sample Collection and Analysis
The protocol mandates the collection of diverse biological samples to provide a multi-dimensional view of the viral reservoir and immune response.
Beyond lymphoid tissue, the study collects peripheral blood, leukocytes via leukapheresis, and optional samples such as cerebrospinal fluid (CSF) and semen/vaginal fluid. Analyses include HIV DNA/RNA quantification, genetic sequencing for viral evolution tracking, and detailed immune cell profiling.
Key Hypotheses and Anticipated Insights
The central hypothesis is that metabolic activity, as measured by FDG-PET, serves as a reliable proxy for the active HIV reservoir.
- Correlation of SUV and Viral Load: Researchers anticipate a positive correlation between PET Standardized Uptake Values (SUV) and the concentration of HIV RNA in biopsy samples.
- Spatial Heterogeneity: By comparing "hot" and "cold" nodes, the study aims to determine if PET imaging can distinguish between active replication sites and latent reservoirs.
- Viral Dynamics: Phylogenetic analysis of rebound virus is expected to reveal the diversity of the initial rebound population before it potentially narrows to a dominant plasma clone.
Limitations and Future Directions
As a pilot study with 12 participants, the primary goal is proof-of-concept. A significant challenge is the non-specificity of FDG, which marks general inflammation as well as HIV-specific activity. Furthermore, ATI involves inherent risks, such as the development of drug resistance or acute retroviral syndrome.
If successful, this imaging-guided biopsy approach could revolutionize how we evaluate HIV cure interventions, providing a visual "map" to monitor whether new therapies effectively suppress the reservoir in its anatomical hiding places.
Summary updated